BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 708K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOFBDB
Voronoi
INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOFBDB
Sanford Burnham Prebys Medical Discovery Institute
BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCERBDB
Hoffmann-La Roche
COMPOUND SERVING AS NLRP3 INHIBITORBDB
Hangzhou Innogate Pharma
A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13BDB
Department of Health And Human Service
INHIBITORS AND DEGRADERS OF JANUS KINASE 2BDB
H. Lee Moffitt Cancer Center and Research Institute
Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitorsBDB
University of Maryland, Baltimore
Substituted 4-phenylpiperidines, their preparation and useBDB
Columbia University
Human plasma kallikrein inhibitorsBDB
Biocryst Pharmaceuticals
Alpha-D-galactoside inhibitors of galectinsBDB
Galecto Biotech
Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitorsBDB
Xenon Pharmaceuticals
Pyrimidine derivative and use thereofBDB
Hubei Bio-Pharmaceutical Industrial Technological Institute
CompoundsBDB
Respivert
Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.BDB
Sichuan University
Agent for treatment of eye diseasesBDB
Daito Chemix
Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.BDB
Argonne National Laboratory
Aryloxmethyl cyclopropane derivatives as PDE10 inhibitorsBDB
Merck Sharp & Dohme
Fused tricyclic dual inhibitors of CDK 4/6 and FLT3BDB
Amgen
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBDB
Merck Sharpe & Dohme